Alprazolam
The active substance of the medicine is alprazolam. It belongs to a group of medicines called benzodiazepines.
Alprazolam acts on the central nervous system, reducing anxiety and depression. It also has a
calming, soothing, and muscle-relaxing effect.
Alprox is used to treat symptoms of anxiety disorders in adults, in situations where the symptoms are severe, prevent normal functioning, or are very troublesome for the patient. This medicine is intended for short-term use only.
Before starting to use this medicine, you should discuss it with your doctor or pharmacist if:
Dependence
Using Alprox may lead to physical and psychological dependence on the medicine.
If the patient notices that they have difficulty stopping the use of this medicine, it may indicate
psychological dependence on it. If physical dependence has occurred, sudden cessation of treatment
may cause withdrawal symptoms (see section 3 "Discontinuation of Alprox"). The risk of dependence increases with the increase in dose and duration of treatment and is greater in patients who abuse alcohol, drugs, and medicines. In order to reduce this risk, the smallest possible dose should be used, and the duration of treatment should be as short as possible. The patient should follow the doctor's recommendations (see section 3). The risk of dependence is also greater in patients who have abused or previously abused prescription drugs or alcohol.
Abuse
A known risk associated with the use of this medicine is its abuse (see section 4).
Abuse of this medicine may lead to overdose and death. The patient should always follow the doctor's recommendations regarding dosage. This medicine may be sought after by people who abuse prescription drugs and should be stored in a place inaccessible to others.
Effect on memory
During treatment with Alprox, memory may be impaired. This usually occurs a few hours after taking the medicine. If such symptoms occur, the patient should contact their doctor.
Effect on mood
Using Alprox may increase the risk of episodes of hypomania (a milder form of mania) and mania (a state of excessive mental excitement, excessive excitement, and increased energy) in patients with depression. If hypomania or mania occurs, the patient should contact their doctor immediately.
In patients with depression, treatment with Alprox may increase the risk of suicidal thoughts or behaviors.
Before starting treatment with Alprox, the patient should consult their doctor.
If treatment with Alprox is necessary and the patient has depression or has had suicidal thoughts or behaviors in the past, the doctor may closely monitor the treatment. The patient should contact their doctor or go to the hospital immediately if they experience any suicidal thoughts or behaviors.
If the patient is scheduled for surgery
The patient should inform their doctor that they are taking Alprox if they are scheduled for surgery.
The patient should consult their doctor if they are under 18 years old. The safety of using this medicine in patients under 18 years old has not been confirmed.
In elderly patients, benzodiazepines and similar medicines should be used with caution due to the existing risk of excessive sedation and/or muscle weakness. This may lead to falls, which can have serious health consequences in this group of patients.
The patient should tell their doctor or pharmacist about all medicines they are currently taking or have recently taken, as well as any medicines they plan to take. This includes both prescription and over-the-counter medicines, as well as herbal preparations or natural products. The patient should remember to mention all other medicines they have taken recently.
Some medicines may cause side effects if taken with alprazolam. The effectiveness of treatment may change if the patient is also taking other medicines. In such cases, the doctor may adjust the treatment or dosage.
Such medicines include, for example:
Medicines that enhance the sedative effect of alprazolam:
Medicines that enhance the effect of alprazolam because they delay its breakdown in the liver:
Medicines that weaken the effect of alprazolam because they increase its breakdown in the liver:
Alprazolam may enhance the effect of medicines such as:
Alcohol enhances the sedative effect of alprazolam.
Concomitant use of Alprox with opioids (strong painkillers, substitution therapy medicines, and some cough medicines) increases the risk of drowsiness, breathing difficulties (respiratory depression), coma, and can be life-threatening. Therefore, concomitant use should only be considered when other treatment methods are not possible. If the doctor has prescribed Alprox with opioids, the patient should use the smallest effective dose, and the duration of treatment should be as short as possible.
The patient should tell their doctor about all opioid medicines they are taking and follow the doctor's recommendations strictly. It may be helpful to inform friends or relatives about the possibility of the patient experiencing the above symptoms. If such symptoms occur, the patient should contact their doctor.
During the next visit, the patient should tell their doctor about taking Alprox.
Tablets should be taken with a glass of water or other liquid.
Alcohol
Alcohol should not be consumed during treatment with Alprox. Alcohol enhances the sedative effect of alprazolam.
Alprox should not be used during pregnancy, unless the doctor considers it absolutely necessary for the treatment of the mother.
Experience with the use of alprazolam in pregnant women is insufficient. Alprox should not be used in case of pregnancy, suspected pregnancy, or planned pregnancy, unless the doctor considers it absolutely necessary. Observations in humans indicate that the use of alprazolam may be harmful to the fetus. If the patient is pregnant or plans to become pregnant, they should discuss the possibility of stopping treatment with their doctor. If the patient is taking Alprox on the day of delivery, they should inform their doctor, as the newborn may experience some withdrawal symptoms from the medicine .
Alprox should not be used during breastfeeding. The medicine may have a harmful effect on the breastfed baby.
If the patient is pregnant or breastfeeding, suspects they may be pregnant, or plans to have a child, they should consult their doctor or pharmacist before using this medicine.
Since alprazolam causes relaxation, muscle relaxation, and sedation, it may impair the ability to drive vehicles and perform tasks that require attention, especially at the beginning of treatment and in case of insufficient sleep. Therefore, the patient should avoid driving vehicles and operating machinery while taking Alprox.
One Alprox tablet contains lactose (in the form of monohydrate): 85.7 mg (0.25 mg tablets), 85.5 mg (0.5 mg tablets), or 171 mg (1 mg tablets). If the patient has previously been diagnosed with intolerance to some sugars, they should contact their doctor before taking Alprox.
This medicine should always be used in accordance with the doctor's recommendations. In case of doubts, the patient should consult their doctor or pharmacist.
Treatment often starts with a small dose, which is gradually increased if necessary, according to the doctor's recommendations. The patient should not change the dosage or stop treatment with Alprox without consulting their doctor. It is recommended that the same doctor starts, conducts, and ends the treatment. The use of medicines such as Alprox may lead to the development of physical and psychological dependence. This risk increases with the increase in dose and duration of treatment and is greater in patients who abuse alcohol, drugs, and medicines. The patient should not give this medicine to others.
Anxiety:
Usually, the initial dose is 0.25 to 0.5 mg three times a day. The maintenance dose usually ranges from 0.5 to 3 mg per day in three divided doses. In elderly patients and patients sensitive to the sedative effect of the medicine, as well as in patients with liver or kidney failure, smaller initial and maintenance doses are recommended than those usually recommended.
The longest treatment duration should not exceed 2 to 4 weeks. Long-term treatment is not recommended.
Alprox should not be used as monotherapy (as the only medicine) in the treatment of depression or in the treatment of anxiety with accompanying depression.
The safety and efficacy of using alprazolam in patients under 18 years old have not been established. Alprox should not be used in this group of patients.
If the patient or someone else, e.g., a child, has taken too much of this medicine by mistake, they should immediately go to the doctor or hospital. If the patient is conscious, they should quickly administer activated charcoal.
When going to the doctor or hospital, the patient should take the medicine packaging with them.
Taking an overdose of alprazolam causes severe fatigue, muscle weakness (coordination disorders), and decreased level of consciousness. It is also possible to experience decreased blood pressure, loss of consciousness, and respiratory depression. Alcohol and other factors that depress the central nervous system potentiate the adverse effects of alprazolam.
The patient should take the missed dose as soon as possible. However, if it is almost time for the next dose, they should not take the missed dose. The patient should not take a double dose to make up for the missed dose. The patient should make sure they have enough Alprox before going on vacation or traveling.
Alprazolam may cause physical and psychological dependence. The risk of dependence is greatest during the use of high doses and long-term treatment. The risk of dependence is greater in patients who abuse alcohol, drugs, and medicines.
Sudden cessation of treatment causes withdrawal symptoms (e.g., headache, muscle pain, severe anxiety, and tension, sleep disturbances, restlessness, confusion, and irritability), and in severe cases - depersonalization (feeling of detachment from one's own person and identity), derealization (feeling of detachment from reality), increased hearing acuity, loss of sensation, tingling in the limbs, hypersensitivity to light, sounds, and touch, hallucinations, seizures. Withdrawal symptoms may occur several days after the end of treatment. Therefore, the patient should not suddenly stoptreatment with Alprox. The dose should be gradually reduced, according to the doctor's recommendations.
In case of any further doubts related to the use of this medicine, the patient should consult their doctor or pharmacist.
Like all medicines, Alprox can cause side effects, although not everybody gets them.
Side effects, if they occur, are usually observed at the beginning of therapy and usually disappear as treatment continues or when the dose is reduced.
The patient should stop using Alprox and immediately contact their doctor if they experience symptoms of angioedema, such as:
Very common( may occur in more than 1 in 10 people):
Common( may occur in up to 1 in 10 people):
Uncommon( may occur in up to 1 in 100 people):
Frequency not known(frequency cannot be estimated from the available data):
During the use of benzodiazepines, such as Alprox, existing depression may be revealed.
Alprazolam may cause physical and psychological dependence. See section 2 "Warnings and precautions".
Sudden cessation of Alprox may cause withdrawal symptoms, such as anxiety, insomnia, and seizures (see section 3 "Discontinuation of Alprox").
Memory disorders may occur, leading to inappropriate behavior (see section 2 "Warnings and precautions").
If the patient experiences any side effects, including any side effects not listed in this leaflet, they should tell their doctor or pharmacist. Side effects can be reported directly to the Department of Monitoring of Adverse Reactions to Medicinal Products of the Office for Registration of Medicinal Products, Medical Devices, and Biocidal Products:
Al. Jerozolimskie 181C, 02-222 Warsaw,
tel.: 22 49-21-301, fax: 22 49-21-309. Website: https://smz.ezdrowie.gov.pl
Side effects can also be reported to the marketing authorization holder.
By reporting side effects, more information can be collected on the safety of the medicine.
Store in a temperature below 25°C.
The container contains a desiccant that protects the tablet from moisture. The patient should not remove the desiccant from the container. The patient should not swallow the desiccant.
The medicine should be stored in a place out of sight and reach of children.
The patient should not use this medicine after the expiry date stated on the carton. The expiry date refers to the last day of the specified month.
Medicines should not be disposed of via wastewater or household waste. The patient should ask their pharmacist how to dispose of medicines that are no longer needed. This will help protect the environment.
0.25 mg tablets: white or almost white uncoated tablets, oval, with a dividing line and marked with "ORN 51", measuring 9 x 6 mm.
0.5 mg tablets: white or almost white uncoated tablets, oval, with a dividing line and marked with "ORN 52", measuring 9 x 6 mm.
1 mg tablets: white or almost white uncoated tablets, round, flat, with beveled edges, with a dividing line and marked with "ORN 50", with a diameter of 9 mm.
The tablet can be divided into equal doses.
Pack sizes:
20, 30, 50, and 100 tablets.
Not all pack sizes may be marketed.
Orion Corporation
Orionintie 1
FI-02200 Espoo
Finland
Orion Corporation, Orion Pharma
Orionintie 1
FI-02200 Espoo
Finland
Orion Corporation Orion Pharma
Joensuunkatu 7
FI-24100 Salo
Finland
To obtain more detailed information about this medicine, the patient should contact the local representative of the marketing authorization holder:
Orion Pharma Poland Sp. z o. o.
kontakt@orionpharma.info.pl
Date of last revision of the leaflet:29.11.2024
Need help understanding this medicine or your symptoms? Online doctors can answer your questions and offer guidance.